FDA moves to open up data on adverse events

02/27/2014 | Bloomberg Businessweek

The FDA is planning to give the public greater access to data on reports of adverse events involving prescription drugs through the openFDA project. Giving doctors and patients more information is a good thing, but it's important that context be provided, PhRMA Senior Counsel Jeff Francer said. "We wouldn't want patients to be scared by just receiving adverse event information in absence of a more full discussion of both the benefits and the risks of a medicine," he said.

View Full Article in:

Bloomberg Businessweek

Published in Brief: